A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares.
Phase of Trial: Phase III
Latest Information Update: 20 Jul 2017
At a glance
- Drugs Rilonacept (Primary) ; Allopurinol
- Indications Gout
- Focus Adverse reactions
- Acronyms UPSURGE
- 03 Oct 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 13 Jan 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 28 Oct 2011 New trial record